Markets must be defined from consumers' view, US states say in GLP-1 antitrust case
By Clayton Vickers ( July 21, 2026, 20:57 GMT | Insight) -- The relevant market in antitrust litigation against Eli Lilly and Novo Nordisk over GLP-1 drugs should be defined from the perspective of consumers, the states of Texas and Louisiana said in an amicus brief filed Tuesday. The relevant market in antitrust litigation against Eli Lilly and Novo Nordisk over GLP-1 drugs should be defined from the perspective of consumers, the states of Texas and Louisiana said in an amicus brief filed Tuesday....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.